No Detail Found!

Nanoparticles of Kirinyuh (Chromolaena odorata (L.) R.M.King & H.Rob.) Leaves Extract as a Candidate for Natural Remedies Lowering Hypercholesterol: In Silico and In vivo Study

Author(s)
Shafira Salwa Salsabil Faculty of Veterinary Medicine,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Vania Putri Ardana Faculty of Veterinary Medicine,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Raden Roro Prakasita Budi Larastiyasa Faculty of Veterinary Medicine,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Inarotul Wardah Pratiwi Faculty of Mathematics and Natural Science,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Rizky Aprillia Widianti Faculty of Mathematics and Natural Science,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Anggi Muhtar Pratama Department of Pharmacology, Faculty of Veterinary Medicine,Universitas Gadjah Mada, Sleman, Yogyakarta, 55281,Indonesia
Abstract
Hypercholesterolemia in recent years has become a serious problem because of its cause of almost half of cases of ischemic heart disease. Alternative medicine most people usually use also has a weakness, namely weak pharmacological effects. This study aims to optimize the pharmacological effect of kirinyuh leaves as an antihypercholesterolemic agent by making nanoparticles preparations. This study used in silico and in vivo studies, the in silico study was done to predict the potential of flavonoid, one of kirinyuh leaves' compounds which can inhibit HMGCoA reductase (HMGCR) enzyme, that have a role of cholesterol making. In vivo study was done to hypercholesterolemia mouse model (n=24) who were given of kirinyuh leaves extract each with 100 mg (T1) and 200 mg/200 g body weight (BW) (T2) dose, and kirinyuh leaves extract in nanoparticle formulas each 1 mL (T3) and 2 mL/200 g BW (T4) every day for 2 weeks. Blood was snipped at the end of treatment for lipid profile analysis. Molecular docking's result showed that flavonoid compounds can reduce hypercholesterolemia by interacting with HMGCR enzymes thus the formation of cholesterol in the liver can be inhibited, therefore T1-T4 are capable to improve blood lipid profile significantly compared to control (P<0.05). The best result is shown in T4 that gave 2 mL/200 g BW dose of nanoparticle formulation with the most reduction of total cholesterol and lipid profile between all the treatment groups. It can be concluded that nanoparticle formulation has better pharmacologist effect.
Publication Details
Page(s) 397-403
Published Journal: Pakistan Veterinary Journal, Volume: 42, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
molecular docking, Nanoparticles., Anti hypercholesterolemia, In silico study, Kirinyuh leaves
0

Citations

0

Downloads

45

Views